A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UCB0159 in Participants With Mild to Moderate Psoriasis, Single Dose Pharmacokinetics and Safety in Healthy Participants.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of the study is to evaluate the safety and pharmacokinetics of UCB0159 administered in participants with mild to moderate plaque psoriasis and evaluate single dose pharmacokinetics and safety of UCB0159 in healthy participants.
Epistemonikos ID: 96e6c3f8bb8bfd9edd44eb35af49d3e6fc3b21df
First added on: Oct 01, 2026